Is E326K glucocerebrosidase a polymorphic or pathological variant?

Molecular Genetics and Metabolism

Volumn 105, Issue 3, 2012, Pages 528-529

  Liou, Benjamin ^a   Grabowski, Gregory A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE;

ALLELE; CATALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; GAUCHER DISEASE; GENOTYPE; HUMAN; LETTER; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN;

BETA-GLUCOSIDASE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; PARKINSON DISEASE;

EID: 84858296346     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.12.002     Document Type: Letter

References (12)

1. Grabowski G.A., Petsko G.A., Kolodny E. Gaucher disease. The Metabolic and Molecular Bases of Inherited Disease 2010, McGraw-Hill, New York. http://genetics.accessmedicine.com, D. Valle, A.L. Beaudet, B. Vogelstein, K.W. Kinzler, S.E. Antonarakis, A. Ballabio, W.S. Sly (Eds.).
2. Grabowski G.A., Kolodny E.H., Weinreb N.J., Rosenbloom B.E., Prakash-Cheng A., Kaplan P., Charrow J., Pastores G.M., Mistry P.K. Gaucher disease: phenotypic and genetic variation. The Metabolic and Molecular Bases of Inherited Diseases 2006, McGraw-Hill, New York. http://genetics.accessmedicine.com, C. Scriver, A. Beaudet, W. Sly, D. Valle (Eds.).
3. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., Bar-Shira A., Berg D., Bras J., Brice A., Chen C.M., Clark L.N., Condroyer C., De Marco E.V., Durr A., Eblan M.J., Fahn S., Farrer M.J., Fung H.C., Gan-Or Z., Gasser T., Gershoni-Baruch R., Giladi N., Griffith A., Gurevich T., Januario C., Kropp P., Lang A.E., Lee-Chen G.J., Lesage S., Marder K., Mata I.F., Mirelman A., Mitsui J., Mizuta I., Nicoletti G., Oliveira C., Ottman R., Orr-Urtreger A., Pereira L.V., Quattrone A., Rogaeva E., Rolfs A., Rosenbaum H., Rozenberg R., Samii A., Samaddar T., Schulte C., Sharma M., Singleton A., Spitz M., Tan E.K., Tayebi N., Toda T., Troiano A.R., Tsuji S., Wittstock M., Wolfsberg T.G., Wu Y.R., Zabetian C.P., Zhao Y., Ziegler S.G. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. The NEJM 2009, 361:1651-1661.
4. Nichols W.C., Pankratz N., Marek D.K., Pauciulo M.W., Elsaesser V.E., Halter C.A., Rudolph A., Wojcieszek J., Pfeiffer R.F., Foroud T. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 2009, 72:310-316.
5. Westbroek W., Gustafson A.M., Sidransky E. Exploring the link between glucocerebrosidase mutations and parkinsonism. Trends Mol. Med. 2011, 17:485-493.
6. Horowitz M., Pasmanik-Chor M., Ron I., Kolodny E.H. The enigma of the E326K mutation in acid β-glucocerebrosidase. Mol. Genet. Metab. 2011, 104:35-38.
7. Park J.K., Tayebi N., Stubblefield B.K., LaMarca M.E., MacKenzie J.J., Stone D.L., Sidransky E. The E326K mutation and Gaucher disease: mutation or polymorphism?. Clin. Genet. 2002, 61:32-34.
8. Montfort M., Chabas A., Vilageliu L., Grinberg D. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: pathogenic changes and "modifier" polymorphisms. Hum. Mutat. 2004, 23:567-575.
9. Liou B., Kazimierczuk A., Zhang M., Scott C.R., Hegde R.S., Grabowski G.A. Analyses of variant acid β-glucosidases: effects of Gaucher disease mutations. J. Biol. Chem. 2006, 281:4242-4253.
10. Dvir H., Harel M., McCarthy A.A., Toker L., Silman I., Futerman A.H., Sussman J.L. X-ray structure of human acid-β-glucosidase, the defective enzyme in Gaucher disease. EMBO Rep. 2003, 4:704-709.
11. Tylki-Szymañska A., Keddache M., Grabowski G.A. Characterization of neuronopathic Gaucher disease among ethnic poles. Genet. Med. 2006, 8:8-15.
12. Zhao H., Bailey L., Arnold G.L., Grabowski G.A. Gaucher's disease: identification of novel mutant alleles and genotype-phenotype relationships. Clin. Genet. 2003, 64:57-64.